ResearcherNanjing General Hospital of Nanjing Military CommandNo recent work listed
Xiaoqin Ji
Matched on OpenAlex author ID A5024724317. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2020: 1 paper · 2021: 2 papers · 2022: 1 paper
Papers 4
- Efficacy of stereotactic body radiation therapy for locoregional recurrent pancreatic cancer after radical resection. Co-author DOI 10.3389/fonc.2022.925043↗
- Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.659987↗
- Study on Motion Management of Pancreatic Cancer Treated by CyberKnife. Co-author DOI 10.3389/fonc.2021.767832↗
- Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced unresectable p… Co-author DOI 10.1007/s00432-019-03066-z↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xixu Zhu · 3 shared papers, 2020–2021 · strength 0.40
- Paper Study on Motion Management of Pancreatic Cancer Treated by CyberKnife. DOI 10.3389/fonc.2021.767832↗
- Paper Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancr… DOI 10.3389/fonc.2021.659987↗
- Paper Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecita… DOI 10.1007/s00432-019-03066-z↗
- Zetian Shen · 2 shared papers, 2020–2021 · strength 0.25
- Paper Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancr… DOI 10.3389/fonc.2021.659987↗
- Paper Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecita… DOI 10.1007/s00432-019-03066-z↗
- Xiangdong Sun · 1 shared paper, 2022 · strength 0.16
- Jing Li · 1 shared paper, 2021 · strength 0.15
- Shenghua Jing · 1 shared paper, 2021 · strength 0.15
- Cheng Yeh Chen · 1 shared paper, 2021 · strength 0.14
- Xiaoyuan Chu · 1 shared paper, 2021 · strength 0.14
- Guichun Huang · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.